Published in Physician Law Weekly, February 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Confirma.
Report 1: Confirma, a provider of computer-aided-detection (CAD) for breast MRI (magnetic resonance imaging), reported that results of a study indicated that automatic volume measurements from the company's CADstream system are predictive of length of recurrence-free survival and support volumetric measurements of tumor response as a surrogate endpoint for survival outcomes.
The study was conducted recently at the University of California, San Francisco, and was led by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly